ICUI
ICU Medical Inc
159.40$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +159.6% | -49.8% | +79.0% | -56.0% | +11.3% | +27.7% | -78.2% | +405.8% | +6.9% | -35.8% | +106.0% | – | |
| – | -2.1% | -2.9% | -0.4% | +0.6% | -4.8% | -6.7% | +0.4% | +2.3% | +7.0% | -7.9% | -0.8% | – | |
| – | -2.4% | +8.5% | -5.2% | +7.0% | +6.3% | -2.7% | +18.7% | +5.4% | -8.9% | +1.0% | -15.3% | – | |
| – | – | -70.8% | +497.2% | -155.1% | – | – | – | – | – | – | – | – | |
| – | +30.2% | -41.0% | +3.2% | -25.3% | +82.8% | -45.0% | +50.5% | +32.2% | -15.2% | -54.1% | +63.8% | – | |
| – | +25.1% | -41.7% | +21.4% | +5.4% | +16.1% | -36.7% | – | -116.0% | -38.8% | -39.1% | +79.7% | – | |
| – | +792.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,758.8% | +21.9% | -97.5% | – | -202.6% | – | – | – | +28,177.4% | +342.3% | – | – | |
| – | – | – | – | – | +26.1% | +266.4% | +317.1% | -87.2% | +17.7% | -82.3% | +847.2% | – | |
| – | +22.7% | +242.0% | -61.3% | 0.0% | -21.1% | +587.8% | +246.2% | -86.8% | +34.2% | +27.9% | +13.9% | – | |
| – | +4,270.1% | -104.9% | – | -80.7% | -140.0% | – | – | -102.8% | – | -338.5% | – | – | |
| – | +459.2% | -54.6% | +132.1% | -65.5% | -36.9% | +170.0% | -129.4% | – | +30.1% | -23.2% | +123.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.